Copyright
©The Author(s) 2025.
World J Cardiol. Jun 26, 2025; 17(6): 106147
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.106147
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.106147
Figure 3 Central illustration.
AFib: Atrial fibrillation; FA: Fatty acid; CPAP: Continuous positive airway pressure; GLP-1RA; Glucagon like peptide-1 receptor agonist; iCa: Intracellular calcium; MASLD: Metabolic dysfunction-associated steatotic liver disease; OSA: Obstructive sleep apnea; RAAS: Renin-angiotensin-aldosterone-system; TNF-α: Tumor necrosis factor-alpha; VEGF: Vascular endothelial growth factor. Created in BioRender (Supplementary material).
- Citation: Bharaj IS, Brar AS, Kahlon J, Singh A, Hotwani P, Kumar V, Sohal A, Batta A. Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis. World J Cardiol 2025; 17(6): 106147
- URL: https://www.wjgnet.com/1949-8462/full/v17/i6/106147.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i6.106147